METTL8 and colorectal cancer: Clinically, based on published datasets in human patients with colorectal cancer (Smith et al., 2010), high level of METTL8 significantly has a lower survival rate than the low-level cohort (Figure 6D, n = 504, p = 0.0024), indicating METTL8 may contribute to therapeutic response in patients with cancer.